Cibus Global LLC (CBUS) - Total Liabilities

Latest as of March 2026: $288.72 Million USD

Based on the latest financial reports, Cibus Global LLC (CBUS) has total liabilities worth $288.72 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Cibus Global LLC - Total Liabilities Trend (2015–2025)

This chart illustrates how Cibus Global LLC's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Cibus Global LLC to evaluate short-term liquidity relative to the company's equity base.

Cibus Global LLC Competitors by Total Liabilities

The table below lists competitors of Cibus Global LLC ranked by their total liabilities.

Company Country Total Liabilities
OptiNose
NASDAQ:OPTN
USA $176.22 Million
Global Lights Acquisition Corp Ordinary Shares
NASDAQ:GLACF
USA $2.99 Million
GEA Grenobl. Elect.
PA:GEA
France €16.51 Million
Macroblock
TWO:3527
Taiwan NT$300.31 Million
Flexopack Société Anonyme Commercial and Industrial Plastics Company
AT:FLEXO
Greece €86.08 Million
Global Lights Acquisition Corp Ordinary Shares
NASDAQ:GLAC
USA $2.99 Million
Favelle Favco Bhd
KLSE:7229
Malaysia RM624.09 Million
Caturkarda Depo Bangunan PT Tbk
JK:DEPO
Indonesia Rp990.41 Billion

Liability Composition Analysis (2015–2025)

This chart breaks down Cibus Global LLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Cibus Global LLC (CBUS) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.37 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 8.14 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.89 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Cibus Global LLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Cibus Global LLC (2015–2025)

The table below shows the annual total liabilities of Cibus Global LLC from 2015 to 2025.

Year Total Liabilities Change
2025-12-31 $283.22 Million +12.28%
2024-12-31 $252.24 Million +22.38%
2023-12-31 $206.12 Million +1257.10%
2022-12-31 $15.19 Million -34.14%
2021-12-31 $23.06 Million -12.82%
2020-12-31 $26.45 Million +3.37%
2019-12-31 $25.59 Million +0.77%
2018-12-31 $25.39 Million +72.85%
2017-12-31 $14.69 Million +319.26%
2016-12-31 $3.50 Million +101.61%
2015-12-31 $1.74 Million --

About Cibus Global LLC

NASDAQ:CBUS USA Biotechnology
Market Cap
$98.47 Million
Market Cap Rank
#19388 Global
#4396 in USA
Share Price
$1.29
Change (1 day)
-1.53%
52-Week Range
$1.16 - $4.05
All Time High
$1574.00
About

Cibus, Inc. is an agricultural biotechnology company that develops and licenses gene-edited plant traits. The company's products enable farmers to achieve higher yields and reduce the use of chemicals, such as fungicides, insecticides and fertilizers, and offer sustainable ingredients. it has patented core technology platform, RTDS, a scalable, standardized, end-to-end, semi-automated and high-th… Read more